Brief: Kaly Initiates Phase Two Cannabis Extract COPD Treatment Study
18/03/2019 17:11
March 18 (Reuters) - Kali Inc KALY.PK :
* KALY INITIATES PHASE TWO CANNABIS EXTRACT COPD TREATMENT
STUDY
Source text for Eikon: ID:nGNX35YTQ2
Further company coverage: KALY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kali
See all newsBrief: KALY-Kali-Extracts RespRx Could Offer Treatment For Coronavirus Symptoms
Brief: Pura Explores Acquisition Of Kaly CBD Confection Assets
Brief: Kaly Confirms Consolidation Plans To Focus On $50 Bln Cannabis Biopharmaceutical Market Opportunity
Brief: Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements
Brief: Kali Says Co Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements